Home

Indrani Lall Franchini

CIK 1708764 · EVP, CLO & Secretary · last filed 2026-07-28

Indrani Lall Franchini is an EVP, CLO & Secretary who has filed 27 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider disposed of $120.4K of AVNS on Jul 28, 2026. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions. 19 SEC filings were submitted jointly with ALEXION PHARMACEUTICALS, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.10M

Companies

2

Total Filings

27

Lifetime Open-Market Net

-$1.44M

Filer Profile

Reported Address
C/O ALEXION PHARMACEUTICALS, INC
100 COLLEGE STREET
NEW HAVEN, CT 06510
Related Filers
ALEXION PHARMACEUTICALS, INC. — 19 joint filings, latest 2021-07-23
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVANOS MEDICAL, INC. (AVNS) Delisted Director 0 $24.99 $0 $0 3 2026-07-28
ALNY EVP, CLO & Secretary 4,133 $266.11 $1.10M -$1.44M 6 2024-02-29

Recent Filings

27 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-28 AVANOS MEDICAL, INC. (AVNS) Delisted Disp (D) −4,817 -$120.4K EDGAR
2026-05-12 AVANOS MEDICAL, INC. (AVNS) Delisted Grant (A) — $0 EDGAR
2025-01-06 AVANOS MEDICAL, INC. (AVNS) Delisted Grant (A) +12,003 $0 EDGAR
2024-02-29 ALNY Mixed +549 -$51.1K EDGAR
2024-02-05 ALNY Mixed +3,584 -$272.1K EDGAR
2023-04-10 ALNY Sell (S) −3,500 -$735.0K EDGAR
2023-03-01 ALNY Grant (A) — $0 EDGAR
2023-02-03 ALNY Mixed +3,500 -$378.6K EDGAR
2022-02-09 ALNY Grant (A) — $0 EDGAR
2021-07-23 — Disp (D) −116,075 $0
Showing 1–10 of 27
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.